This Non-alcoholic Steatohepatitis (NASH) Diagnostics Market report covers the size, share, trends, forecast, status of import and export, supply chain management, distribution channels, price, profit, sale and others vital elements.

New York, NY -- (SBWire) -- 07/11/2019 --Incorporated with Info-graphics, charts, 35 tables and 55 figures, this 117-page research report "Non-alcoholic Steatohepatitis (NASH) Diagnostics Market Size, Type Analysis, Application Analysis, End-Use Industry Analysis, Regional Outlook, Competitive Strategies And Forecasts, 2018 - 2023" is based on a complete research of the entire Global market and covering all its sub-segments through comprehensively thorough classifications. Insightful analysis and assessment are created from superior primary and secondary information sources with data and information derived from industry specialists across the value chain. The report provides historical market data for 2014-2018, base year estimates for 2018, and forecasts from 2018 to 2023.

The major players covered in this report are:
GENFIT SA, Echosens, SuperSonic Imagine, BioPredictive, One Way Liver, S.L. (OWL), VLVbio AB, Quest Diagnostics Incorporated , Prometheus Laboratories Inc., Siemens Healthcare GmbH., Exalenz Bioscience Ltd.

Request for FREE sample copy of the report for an overview of complete report @ https://www.marketexpertz.com/sample-enquiry-form/43425

Global Non-alcoholic Steatohepatitis (NASH) Diagnostics Market:
The global epidemic of type 2 diabetes and rising obesity are leading to the growing prevalence of non-alcoholic steatohepatitis (NASH), especially in developed nations. According to the NASH Education Program, NASH affects around 12% of the world's adult population. More than 80% of patients with NASH are obese, 44% have type 2 diabetes, and 72% have abnormal blood lipids (triglycerides and cholesterol). The increasing prevalence of these ailments is expected to drive the demand for NASH diagnostics over the 2018-2023 period.

Diagnostic techniques segment insights:
Liver biopsy is one of the broadly accepted diagnostic techniques for NASH detection since it provides accurate results. Liver biopsy is preferred by medical practitioners owing to its ability to determine the degree of steatosis and inflammation accurately. However, the invasive liver biopsy procedure has several disadvantages, such as pain, bleeding, and the possibility of injuring other organs. Thus, the adoption of non-invasive imaging techniques and biomarkers is anticipated to increase significantly. As a result, the market size of the liver biopsy technique is expected to grow at a slower rate than biomarkers, in developed regions like North America and Europe.

Direct Order Now [$3800] @ https://www.marketexpertz.com/checkout-form/43425

Geographically, this report studies the key regions, focuses on product sales, value, market share and growth opportunity in these regions, covering:
- United States
- Europe
- China
- Japan
- Southeast Asia
- India

We can also provide the customized separate regional or country-level reports, for the following regions:
North America, United States, Canada, Mexico, Asia-Pacific, China, India, Japan, South Korea, Australia, Indonesia, Singapore, Rest of Asia-Pacific, Europe, Germany, France, UK, Italy, Spain, Russia, Rest of Europe, Central & South America, Brazil, Argentina, Rest of South America, Middle East & Africa, Saudi Arabia, Turkey, Rest of Middle East & Africa

The research provides answers to the following key questions:
- What will be the growth rate and the market size of the Non-alcoholic Steatohepatitis (NASH) Diagnostics industry for the forecast period 2018-2023?
- What are the major driving forces expected to impact the development of the Non-alcoholic Steatohepatitis (NASH) Diagnostics market across different regions?
- Who are the major driving forces expected to decide the fate of the industry worldwide?
- Who are the prominent market players making a mark in the Non-alcoholic Steatohepatitis (NASH) Diagnostics market with their winning strategies?
- Which industry trends are likely to shape the future of the industry during the forecast period 2018-2023?
- What are the key barriers and threats believed to hinder the development of the industry?
- What are the future opportunities in the Non-alcoholic Steatohepatitis (NASH) Diagnostics market?

Why buy?
o Understand the demand for global Non-alcoholic Steatohepatitis (NASH) Diagnostics to determine the viability of the market.
o Identify the developed and emerging markets where Non-alcoholic Steatohepatitis (NASH) Diagnostics services are offered.
o Identify the challenge areas and address them.
o Develop strategies based on the drivers, trends and highlights for each of the segments.
o Evaluate the value chain to determine the workflow and to get an idea of the current position where you are placed.
o Recognize the key competitors of this market and respond accordingly.
o Knowledge of the initiatives and growth strategies taken up by the major companies and decide on the direction for further growth.
o Define the competitive positioning by comparing the products and services with the key players in the market.

Key elements from table of content:
Chapter 8: Competitive landscape
8.1. GENFIT SA
8.1.a. Company snapshot
8.1.b. Product offerings
8.1.c. Growth strategies
8.1.d. Initiatives
8.1.e. Geographical presence
8.1.f. Key numbers
Note: Similar information areas will be covered for the remaining competitors
8.2. Echosens
8.3. SuperSonic Imagine
8.4. BioPredictive
8.5. One Way Liver, S.L. (OWL)
8.6. VLVbio AB
8.7. Quest Diagnostics Incorporated
8.8. Prometheus Laboratories Inc.
8.9. Siemens Healthcare GmbH.
8.10. Exalenz Bioscience Ltd.
Continued…

Browse complete report description @ https://www.marketexpertz.com/industry-overview/non-alcoholic-steatohepatitis-nash-diagnostics-market

About MarketExpertz
Planning to invest in market intelligence products or offerings on the web? Then marketexpertz has just the thing for you - reports from over 500 prominent publishers and updates on our collection daily to empower companies and individuals catch-up with the vital insights on industries operating across different geography, trends, share, size and growth rate. There's more to what we offer to our customers. With marketexpertz you have the choice to tap into the specialized services without any additional charges.

Contact Us:
John Watson
Head of Business Development
Market Expertz | Web: www.marketexpertz.com
Direct Line: +1-800-819-3052
E-mail: sales@marketexpertz.com
News: www.marketexpertz.com/market-news